Richard J., Goetz A.-A., Feufack-Donfack L. B., Rottmann M., Mäser P., Blandin S. A., Davioud-Charvet E. (2024) Polyaromatic or heteroaromatic compounds exhibiting anti-Plasmodial activities. EP24307227.9.

Mecheri, S., Silvie, O., Peronet, R., Briquet, S. (2023) Genetically modified plasmodium parasite expressing il-6 – use to raise an immune response in a host against malaria at the pre-erythrocytic stage of development of the parasite. WO2023012354 PCT/EP2022/072142.

Blanchard, N., Suberbielle, E., Belloy, M., Schmitt, B. (2023) Methods of treating cognitive decline. PCT/FR2023/000152.

Donzel M., Roignant M., Elhabiri M., Davioud-Charvet E. (2021a). Preparation of heteroaromatic analogues of 3-benzylmenadione derivatives, EU N° 21305755.7 déposée le 4 juin 2021. World Intellectual Property Organization, WO2022254034 A1 2022-12-08.

Trometer N., Donzel M., Roignant M., Davioud-Charvet E. (2021b) Preparation of 6-substituted menadiones, EU N° 21305973.6, déposée le 13 juillet, 2021. EP2022069555, le 13 juillet 2022. 6-Substituted menadiones and their preparation. World Intellectual Property Organization, WO2023285509 A1 2023-01-1

Donzel M., Elhabiri M., Davioud-Charvet E. (2021c) «Photoredox radical benzylation process », EU N° 21305263.2 déposée le 5 mars 2021. PCT No. PCT/EP2022/055568, Priorité: EP 21305263.2, March 4, 2022. Photoredox radical benzylation process. World Intellectual Property Organization, WO2022184904 A1 2022-09-09

Bras-Gonçalves, R. L., J.L., E. Petitdidier and G. A. (2018) Epitopes, composés peptidiques mono-ou multiépitopiques et vaccin contre la leishmaniose N°FR18/00533.

Blanchard, N. and J. Lopez (2016) Procédé pour le traitement d'un cancer et de maladies infectieuses. PCT/EP2015/071997. WO2016046321A1. 2016-03-31

Vincendeau, P., J.-L. Lemesre and E. Pays (2016) Traitement et detection des trypanosomoses. PCT/FR2016/051170. WO2016185135A1. 2016-11-24

Hernandez-Rivas, R. and A. Scherf (2016) Cathepsin C-like protease regulates DNA replication by histone N-terminal clipping in malaria parasites. DI 2016-68 PfDPAP2-AF.

Mécheri, S., R. Ménard and C. Demarta-Gatsi (2016) Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine. DI2016-46AF.

Blanchard, N. and J. Lopez (2016) Procédé pour le traitement d'un cancer et de maladies infectieuses. PCT/EP2015/071997. WO2016046321A1. 2016-03-31

Sereno, D., G. Labesse, J.-F. A. Guichou, C. Loeuillet and D. I. Garcia (2015) Compounds for the treatment and/or prevention of parasitic diseases and method of production thereof. EP13177129.7A. EP2826769A1. 2015-01-21

Malmquist, N. and A. Scherf (2015) Discovering inhibitors of P. falciparum HP1 protein from the GSK Tres Cantos Anti-Malarial set of small molecules. . DI 2015-41.

Lemesre, J.-L., G.-M. Papierok, R. E. Bras-Goncalves and E. Petitdidier-Lesin (2015) Composition vaccinale pour la prevention et/ou le traitement de leishmanioses, peptides immunogenes et procede d'obtention. PCT/IB2014/066425. WO2015079420A2. 2015-06-04

Papierok, G.-M., J.-L. Lemesre, S. Gueguen, R. E. B. Goncalves and E. Petitdidier-Lesin (2014) Vaccins monovalents et polyvalents contre leishmania. PCT/FR2013/000373. WO2014102471A1. 2014-07-03

Mercier, C., M.-F. Delauw, H. Pelloux and H. Fricker-Hidalgo (2014) Antigenes gra recombinants et leur application pour le diagnostic precoce de la toxoplasmose. PCT/EP2013/071578. WO2014060448A1. 2014-04-24

Malmquist, N., P. Chen and A. Scherf (2014) Malaria parasite histone methyltransferase enzymes as potential drug targets and inhibibitors as potential anti-malarials. DI 2014-46.

Pietschmann, T., S. Haid, J. Gentzsch, C. Grethe, E. Davioud-Charvet, D. A. Lanfranchi, M. Elhabiri and X. Benlloch-Martin (2013) Flavone derivatives and their use. EP12002056.5A. EP2641904A1. 2013-09-25

Linares, V. C., T. Baltz and M. Thonnus (2012) Anti-trypanosome therapeutic and diagnostic applications. EP10779306A. EP2499157A1. 2012-09-19

Davioud-Charvet, E., D. A. Lanfranchi, L. Johann and D. L. Williams (2012) Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents. EP2505583A1.

Tomavo, S., P.-J. Sloves and T. Mouveaux (2012) Conditional knockout mutants of sortilin-like receptor in apicomplexan parasites and uses thereof. EP2723355B1.